Noerr advises Analytik Jena on squeeze-out

Noerr advised Analytik Jena AG on a squeeze-out procedure. A Noerr team led by the Frankfurt-based partners Dr Stephan Schulz and Dr Laurenz Wieneke assisted the company comprehensively during the transaction, especially in preparing and conducting an extraordinary general meeting. The meeting approved the transfer of shares from the minority shareholders to the main shareholder, a subsidiary of the Swiss measuring instrument manufacturer Endress+Hauser. Endress+Hauser will now acquire all remaining shares in Analytik Jena AG in return for appropriate cash compensation.

Analytik Jena AG relies on Noerr’s expertise in corporate and capital markets law on a regular basis. For example, teams led by the Frankfurt-based partners advised the company in 2013 both on a capital increase with subscription rights as well as on the mandatory public offer of Endress+Hauser under the German Securities Acquisition and Takeover Act. In connection with the mandatory public offer, Noerr also acted for the major shareholder and CEO Klaus Berka to conclude an option agreement with Endress+Hauser.

Advisors to Analytik Jena AG: Noerr LLP

Dr Stephan Schulz, Dr Laurenz Wieneke (joint lead)

Dr Dominik Kloka (all Capital Markets, Frankfurt)